Home › NDC Lookup › Ingredients › Arum Triphyllum, Aconitum Napellus, Apis... › 62106-1229-03
Angiplex Arum triphyllum, Aconitum napellus, Apis mellifica, Belladonna, Phytolacca decandra, Kali bichromicum, Lachesis mutus, Mercurius solubilis 4 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 10 [hp_X]/1; 10 [hp_X]/1; 10 [hp Tablet, 30-count — NDC 62106-1229-03 package photo

Angiplex Arum triphyllum, Aconitum napellus, Apis mellifica, Belladonna, Phytolacca decandra, Kali bichromicum, Lachesis mutus, Mercurius solubilis 4 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 10 [hp_X]/1; 10 [hp_X]/1; 10 [hp Tablet, 30-count

by Seroyal USA · 1 BLISTER PACK in 1 BOX (62106-1229-3) / 30 TABLET in 1 BLISTER PACK
NDC 62106-1229-03
🏷️ FDA NDC (as labeled) 62106-1229-3 billing pads the package segment with a zero
OTC On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 62106-1229-3
Product NDC 62106-1229
11-digit billing NDC 62106122903
UNII DM64K844DM, U0NQ8555JD, 7S82P3R43Z, WQZ3G9PF0H, 11E6VI8VEG, T4423S18FM +2 more
SPL Set ID 0d04b1a0-6c43-5f25-e054-00144ff8d46c
Established class (EPC) Standardized Insect Venom Allergenic Extract
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production
Chemical class Allergens; Bee Venoms
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2015-01-19
Route SUBLINGUAL
Dosage form TABLET
Substance ARISAEMA TRIPHYLLUM ROOT; ACONITUM NAPELLUS; APIS MELLIFERA; ATROPA BELLADONNA; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS
Why two NDCs? The FDA registers this code as 62106-1229-3 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 62106-1229-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerSeroyal USA
Labeler code62106
First marketedJan 2015
Product typeHuman Otc Drug
Portfolio129 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

Angiplex is a homeopathic tablet taken under the tongue. It contains eight homeopathic ingredients including aconitum, apis mellifica, belladonna, phytolacca, potassium dichromate, lachesis, mercurius solubilis, and arisaema triphyllum. In homeopathic practice, these substances are traditionally used to address symptoms related to throat and respiratory discomfort. Homeopathic products are marketed based on homeopathic tradition and theory; the FDA does not evaluate homeopathic products for effectiveness.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white
ShapeRound
Size9 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII K679OBS311
    Carboxymethylcellulose sodium is a plant-derived thickening agent made from cellulose. In medicines, it acts as a binder to hold ingredients together, a disintegrant to help the tablet break apart, or a thickener in liquids.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII VCQ006KQ1E
    Xylitol is a naturally occurring sugar alcohol derived from plants. It's used in medicines as a sweetener, bulking agent, and to improve taste, especially in liquid formulations and chewable tablets.

4 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients Lactose monohydrate (milk), magnesium stearate, sodium carboxymethylcellulose, xylitol

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Angiplex 4 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 10 [hp_X]/1; 10 [hp_X]/1; 10 [hpthis 62106-1229-03 Seroyal 30 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2015
On the market since
Jan 2015
📍
2026
Currently FDA-listed
11 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Angiplex (this brand).

Top reported reactions

Abdominal Distension1
Diarrhoea1
Gastrointestinal Disorder1

Reporter sex

1 reports
Female · 100%
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
62106-1229-03 You're viewing this 1 BLISTER PACK in 1 BOX (62106-1229-3) / 30 TABLET in 1 BLISTER PACK 2015-01-19 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Angiplex Arum triphyllum, Aconitum napellus, Apis mellifica, Belladonna, Phytolacca decandra, Kali bichromicum, Lachesis mutus, Mercurius solubilis 4 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 8 [hp_X]/1; 10 [hp_X]/1; 10 [hp_X]/1; 10 [hp TABLET is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 62106-1229-3, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 62106-1229-03, written without dashes as 62106122903. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 62106-1229-03, the first segment (62106) is the labeler code FDA assigned to Seroyal USA; the middle segment (1229) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (03) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Seroyal USA. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Seroyal USA is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🆘 Overdosage 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 74 words ▾

Uses For the temporary relief of symptoms associated with sore throat dry throat Directions Adults and adolescents (12 years and older): At the first sign of symptoms, dissolve one tablet under the tongue every half hour to one hour. When symptoms subside, decrease frequency to every four hours. Once the symptoms are gone, continue taking one tablet daily for three more days.

Children (under 12 years): Take under the direction of your healthcare practitioner.

⏱️ Dosage and Administration 61 words ▾

Directions Adults and adolescents (12 years and older): At the first sign of symptoms, dissolve one tablet under the tongue every half hour to one hour. When symptoms subside, decrease frequency to every four hours. Once the symptoms are gone, continue taking one tablet daily for three more days. Children (under 12 years): Take under the direction of your healthcare practitioner.

⚠️ Warnings 118 words ▾

Warnings Sore throat warning: Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult physician promptly. Do not use more than 2 days or administer to children under 3 years of age unless directed by physician.

Stop use and ask a doctor if symptoms continue to persist after three days of use or are accompanied by a fever. Do not use if you have ever had an allergic reaction to this product or any of its ingredients. If pregnant or breastfeeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away

🆘 Overdosage 15 words ▾

In case of overdose, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 57 words ▾

Active ingredients Each tablet contains: Aconitum napellus (Aconite) Whole Plant 8X Apis mellifica (Honey bee) 8X Arum triphyllum (Indian turnip) Underground Parts 4X Belladonna (Deadly nightshade) Whole Plant 8X (< 1.25 x 10-10 % alkaloids, calculated) Kalium bichromicum (Potassium bichromate) 10X Lachesis mutus (Bushmaster) Venom 10X Mercurius solubilis (Hahnemann's soluble mercury) 10X Phytolacca decandra (Pokeweed) Root 8X

🧪 Inactive Ingredients 10 words ▾

Inactive ingredients Lactose monohydrate (milk), magnesium stearate, sodium carboxymethylcellulose, xylitol

🎯 Purpose 13 words ▾

Uses For the temporary relief of symptoms associated with sore throat dry throat

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 62106-1209-00 · Seroyal 62106-1233-00 · Seroyal →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.